| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872394 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
Extreme-aged nonagenarian patients may have excellent outcomes from TAVR at 30-day and midterm follow-up. Alternative access TAVR is associated with higher morbidity and mortality than transfemoral TAVR. Referral for TAVR of nonagenarians should not be precluded based on age alone.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael O. MD, Vinod H. MD, Hanna A. MD, PhD, Jose C. MD, Eric L. MD, Patrick D. MS, Chandan M. MD, Bradley G. MD, Kreton MD, Chun MD, Robert A. MD, James P. MD, Amy PA, Patricia NP, Peter MD, Stamatios MD, Vasilis C. MD,